Peptide record

TPDB05427

Antibacterial Anticancer Antifungal Toxicity standard
35 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05427
Antibacterial Anticancer Antifungal Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 DRAMP Peptipedia CancerPPD 2.0 dbACP Antifungipept ToxinPred 3.0
standard
No
A 35-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, DRAMP, Peptipedia, and other sources, with an available 3D structural model.
Sequence
GIKEMLCNMACAQTVCKKSGGPLCDTCQAACKALG
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C143H248N42O46S8
RHFWY
C
3548.28
8.02
4
2
12
+2
0.43
0.269
67.14
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
375
0.11
12
Residue Composition
number
5
A
0
R
1
N
1
D
6
C
1
E
2
Q
4
G
0
H
1
I
3
L
4
K
2
M
0
F
1
P
1
S
2
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 5 R: 0 N: 1 D: 1 C: 6 E: 1 Q: 2 G: 4 H: 0 I: 1 L: 3 K: 4 M: 2 F: 0 P: 1 S: 1 T: 2 W: 0 Y: 0 V: 1
Chemical Descriptors
35 reviewed residue count
C143H248N42O46S8 sequence-only estimate (linear, free termini)
3548.28 sequence-only estimate (linear, free termini)
8.02 sequence-only estimate (linear, free termini)
+2 sequence-only estimate (linear, free termini)
0.43 sequence-only estimate (linear, free termini)
0.269 sequence-only estimate (linear, free termini)
Evidence Records 6 records
Evidence 1 Activity

Activity

MIC
Antibacterial
1.6 µM

Target

C. glutamicum

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antibacterial
DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against C. glutamicum (MIC 1.6 uM), B. subtilis (MIC 1.6 uM), E. coli (MIC 12.5 uM ), P. aeruginosa, A2058 (MIC 25 uM). High
Evidence 2 Activity

Activity

MIC
Antibacterial
1.6 µM

Target

B. subtilis

Source & Reference

DRAMP

Other

Active against C. glutamicum (MIC 1.6 uM), B. subtilis (MIC 1.6 uM), E. coli (MIC 12.5 uM ), P. aeruginosa, A2058 (MIC 25 uM). Highly toxic to the human mela
Evidence 3 Activity

Activity

MIC
Antifungal
1.6 µM

Target

C. glutamicum

Source & Reference

DRAMP Antifungipept

Other

Source Activity Label Source Definition
Antifungal
DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against C. glutamicum (MIC 1.6 uM), B. subtilis (MIC 1.6 uM), E. coli (MIC 12.5 uM ), P. aeruginosa, A2058 (MIC 25 uM). High
Evidence 4 Activity

Activity

MIC
Antifungal
1.6 µM

Target

B. subtilis

Source & Reference

DRAMP Antifungipept

Other

Active against C. glutamicum (MIC 1.6 uM), B. subtilis (MIC 1.6 uM), E. coli (MIC 12.5 uM ), P. aeruginosa, A2058 (MIC 25 uM). Highly toxic to the human mela
Evidence 5 Activity

Activity

IC50
Toxicity
7.5 µM
Cytotoxic
IC50 | 7.5 | µM | target cell: Human fibroblasts MRC-5

Target

Human fibroblasts MRC-5

Source & Reference

NA
DBAASP
Isolation and Characterization of Antimicrobial Peptides With Unusual Disulfide Connectivity From the Colonial Ascidian Synoicum turgens | Mar Drugs | 2020
Evidence 6 Activity

Activity

IC50
Toxicity
7.5 µM
Cytotoxic
Cytotoxicity: [Ref.31940927]Cytotoxicity: Human fibroblasts MRC-5(IC50=7.5 µM).

Source & Reference

NA
DRAMP
Mar Drugs. 2020 Jan 12 18(1):51.